Role of Nitric Oxide Production and Matrix Protease Activity in Cruciate Ligament Degeneration 87References
Abramson SB. Nitric oxide in inflammation and pain
associated with osteoarthritis. Arthritis Res Ther
2008;10:S2.
Amiel D, Billings E, Jr, Harwood FL. Collage-
nase activity in anterior cruciate ligament: protec-
tive role of the synovial sheath. J Appl Physiol
1990;69:902–906.
Amin AR, Di Cesare PE, Vyas P,et al. The expression
and regulation of nitric oxide synthase in human
osteoarthritis-affected chondrocytes: evidence for
up-regulated neuronal nitric oxide synthase. J Exp
Med 1995;182:2097–2102.
Bezerra MM, Brain SD, Greenacre S,et al.Reac-
tive nitrogen species scavenging, rather than nitric
oxide inhibition, protects from articular cartilage
damage in rat zymosan-induced arthritis. Br J Phar-
macol 2004;141:172–182.
Boileau C, Martel-Pelletier J, Moldovan F,et al.The
in situup-regulation of chondrocyte interleukin-
1-converting enzyme and interleukin-18 levels
in experimental osteoarthritis is mediated by
nitric oxide. Arthritis Rheum 2002;46:2637–
2647.
Boland L, Danger R, Cabon Q,et al. MMP-2 as an
early synovial biomarker for cranial cruciate liga-
ment disease in dogs. Vet Comp Orthop Traumatol
2014;27:210–215.
Bozynski CC, Kuroki K, Stannard JP,et al.Evalua-
tion of partial transection versus synovial debride-
ment of the ACL as novel canine models for man-
agement of ACL injuries. J Knee Surg 2015;28:404–
410.
Cao M, Stefanovic-Racic M, Georgescu HI,et al. Does
nitric oxide help explain the differential healing
capacity of the anterior cruciate, posterior cruciate,
and medial collateral ligaments? Am J Sports Med
2000;28:176–182.
Del Carlo M, Jr, Loeser RF. Nitric oxide-mediated
chondrocyte cell death requires the generation
of additional reactive oxygen species. Arthritis
Rheum 2002;46:394–403.
Del Carlo M, Jr, Loeser RF. Cell death in osteoarthri-
tis. Curr Rheumatol Rep 2008;10:37–42.
Di Mauro D, Bitto L, D’Andrea L,et al.Behaviour
of nitric oxide synthase isoforms in inflamma-
tory human joint diseases: an immunohistochem-
ical study. Ital J Anat Embryol. 2006;111:111–123.
Doom M, de Bruin T, de Rooster H, et al.
Immunopathological mechanisms in dogs with
rupture of the cranial cruciate ligament. Vet
Immunol Immunopathol 2008;125:143–161.
Foos MJ, Hickox JR, Mansour PG,et al. Expression of
matrix metalloprotease and tissue inhibitor of met-
alloprotease genes in human anterior cruciate liga-
ment. J Orthop Res 2001;19:642–649.
Forterre S, Zurbriggen A, Spreng D.In vitroeffect
of different mediators of apoptosis on canine cra-
nial and caudal cruciate ligament fibroblasts and
its reversibility by pancaspase inhibitor zVAD.fmk.
Vet Immunol Immunopathol 2011;139:264–270.
Forterre S, Zurbriggen A, Spreng D. Nitric oxide
induces cell death in canine cruciate ligament cells
by activation of tyrosine kinase and reactive oxy-
gen species. BMC Vet Res 2012;8:40.
Fujita Y, Hara Y, Nezu Y, et al. Proinflamma-
tory cytokine activities, matrix metalloproteinase-
3 activity, and sulfated glycosaminoglycan con-
tent in synovial fluid of dogs with naturally
acquired cranial cruciate ligament rupture. Vet
Surg 2006;35:369–376.
Goggs R, Carter SD, Schulze-Tanzil G,et al. Apop-
tosis and the loss of chondrocyte survival sig-
nals contribute to articular cartilage degradation in
osteoarthritis. Vet J 2003;166:140–158.
Gyger O, Botteron C, Doherr M,et al. Detection and
distribution of apoptotic cell death in normal and
diseased canine cranial cruciate ligaments. Vet J
2007;174:371–377.
Hancock CM, Riegger-Krugh C. Modulation of pain
in osteoarthritis: the role of nitric oxide. Clin J Pain
2008;24:353–365.
Hayashi K, Manley PA, Muir P. Cranial cruciate lig-
ament pathophysiology in dogs with cruciate dis-
ease: a review. J Am Anim Hosp Assoc 2004;40:385–
390.
Hasegawa A, Nakahara H, Kinoshita M,et al.Cel-
lular and extracellular matrix changes in anterior
cruciate ligaments during human knee aging and
osteoarthritis. Arthritis Res Ther 2013;15:R29.
Hauselmann HJ, Stefanovic-Racic M, Michel BA, ̈ et al.
Differences in nitric oxide production by superfi-
cial and deep human articular chondrocytes: impli-
cations for proteoglycan turnover in inflammatory
joint diseases. J Immunol 1998;160:1444–1448.
Hofer D, Forterre S, Schweighauser A,et al. Selec-
tive iNOS-inhibition does not influence apoptosis
in ruptured canine cranial cruciate ligaments. Vet
Comp Orthop Traumatol 2009;22:198–203.
Itoh T, Matsuda H, Tanioka M,et al. The role of matrix
metalloproteinase-2 and matrix metalloproteinase-
9 in antibody-induced arthritis. J Immunol
2002;169:2643–2647.
Krayer M, Rytz U, Oevermann A,et al. Apoptosis
of ligamentous cells of the cranial cruciate liga-
ment from stable stifle joints of dogs with partial
cranial cruciate ligament rupture. Am J Vet Res
2008;69:625–630.
Kroncke KD, Fehsel K, Kolb-Bachofen V. Inducible
nitric oxide synthase and its product nitric oxide, a
small molecule with complex biological activities.
Biol Chem Hoppe Seyler 1995;376:327–343.
Lepetsos P, Papavassiliou AG. ROS/oxidative stress
signaling in osteoarthritis. Biochim Biophys Acta
2016;1862:576–591.
Liang Q, Wang XP, Chen TS. Resveratrol pro-
tects rabbit articular chondrocyte against sodium
nitroprusside-induced apoptosis via scavenging
ROS. Apoptosis 2014;19:1354–1363.